{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T15:06:19Z","timestamp":1787238379462,"version":"build-2736575974"},"reference-count":59,"publisher":"Public Library of Science (PLoS)","issue":"9","license":[{"start":{"date-parts":[[2014,9,5]],"date-time":"2014-09-05T00:00:00Z","timestamp":1409875200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0106929","type":"journal-article","created":{"date-parts":[[2014,9,5]],"date-time":"2014-09-05T15:00:22Z","timestamp":1409929222000},"page":"e106929","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":17,"title":["The Protective Role of Fucosylated Chondroitin Sulfate, a Distinct Glycosaminoglycan, in a Murine Model of Streptozotocin-Induced Diabetic Nephropathy"],"prefix":"10.1371","volume":"9","author":[{"given":"Conrado L. R.","family":"Gomes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina L.","family":"Le\u00e3o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolina","family":"Venturotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e9 L.","family":"Barreira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriela","family":"Guimar\u00e3es","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto J. C.","family":"Fonseca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodrigo S.","family":"Fortunato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paulo A. S.","family":"Mour\u00e3o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alvimar G.","family":"Delgado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina M.","family":"Takiya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maurilo","family":"Leite","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2014,9,5]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1093\/ndt\/gfp757","article-title":"Diabetic kidney disease: act now or pay later","volume":"25","author":"RC Atkins","year":"2010","journal-title":"Nephrol Dial Transplant"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1210\/er.2003-0018","article-title":"From hyperglycemia to diabetic kidney disease: the role of metabolic, hemodynamic, intracellular factors and growth factors\/cytokines","volume":"25","author":"BF Schrijvers","year":"2004","journal-title":"Endocr Rev"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1152\/physrev.00055.2006","article-title":"Properties of the glomerular barrier and mechanisms of proteinuria","volume":"88","author":"B Haraldsson","year":"2008","journal-title":"Physiol Rev"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/BF00285287","article-title":"Albuminuria reflects widespread vascular damage. The Steno hypothesis","volume":"32","author":"T Deckert","year":"1989","journal-title":"Diabetologia"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1038\/ki.2008.128","article-title":"Proteinuria in diabetic kidney disease: A mechanistic viewpoint","volume":"74","author":"JA Jefferson","year":"2008","journal-title":"Kidney Int"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1083\/jcb.86.2.688","article-title":"Increased permeability of the glomerular basement membrane to ferritin after removal of glycosaminoglycans (heparan sulfate) by enzyme digestion","volume":"86","author":"YS Kanwar","year":"1980","journal-title":"J Cell Biol"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1038\/ki.1992.15","article-title":"A monoclonal antibody against GBM heparan sulfate induces an acute selective proteinuria in rats","volume":"41","author":"J van den Born","year":"1992","journal-title":"Kidney Int"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1007\/BF00398060","article-title":"Expression of glomerular extracellular matrix components in human diabetic nephropathy: decrease of heparan sulfate in the glomerular basement membrane","volume":"37","author":"JT Tamsma","year":"1994","journal-title":"Diabetologia"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1681\/ASN.2006070692","article-title":"In vivo degradation of heparan sulfates in the glomerular basement membrane does not result in proteinuria","volume":"18","author":"TJ Wijnhoven","year":"2007","journal-title":"J Am Soc Nephrol"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1038\/ki.2008.159","article-title":"Loss of heparan sulfate glycosaminoglycan assembly in podocytes does not lead to proteinuria","volume":"74","author":"S Chen","year":"2008","journal-title":"Kidney Int"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"2044","DOI":"10.1093\/ndt\/gfn758","article-title":"Glomerular filtration is normal in the absence of both agrin and perlecan-heparan sulfate from the glomerular basement membrane","volume":"24","author":"S Goldberg","year":"2009","journal-title":"Nephrol Dial Transplant"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1038\/sj.ki.5002706","article-title":"Reduction of anionic sites in the glomerular basement membrane by heparanase does not lead to proteinuria","volume":"73","author":"MJ van den Hoven","year":"2008","journal-title":"Kidney Int"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"139","DOI":"10.2353\/ajpath.2007.061116","article-title":"Harvey SJ, Jarad G, Cunningham J, Rops AL, van der Vlag J, et al. Disruption of glomerular basement membrane charge through podocyte-specific mutation of agrin does not alter glomerular permselectivity","volume":"171","journal-title":"Am J Pathol"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1007\/s00125-007-0879-6","article-title":"Heparanase induces a differential loss of heparan sulfate domains in overt diabetic nephropathy","volume":"51","author":"TJ Wijnhoven","year":"2008","journal-title":"Diabetologia"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"2172","DOI":"10.2337\/diabetes.54.7.2172","article-title":"Heparanase-1 gene expression and regulation by high glucose in renal epithelial cells: potential role in the pathogenesis of proteinuria in diabetic patients","volume":"54","author":"JB Maxhimer","year":"2005","journal-title":"Diabetes"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"2853","DOI":"10.1093\/ndt\/gfr732","article-title":"Urinary heparanase activity in patients with Type 1 and Type 2 diabetes","volume":"27","author":"AL Rops","year":"2012","journal-title":"Nephrol Dial Transplant"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"e17312","DOI":"10.1371\/journal.pone.0017312","article-title":"Heparanase Levels Are Elevated in the Urine and Plasma of Type 2 Diabetes Patients and Associate with Blood Glucose Levels","volume":"6","author":"I Shafat","year":"2011","journal-title":"PLoS One"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"208","DOI":"10.2337\/db11-1024","article-title":"Heparanase is essential for the development of diabetic nephropathy in mice","volume":"61","author":"N Gil","year":"2012","journal-title":"Diabetes"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.1038\/sj.ki.5001985","article-title":"Increased expression of heparanase in overt diabetic nephropathy","volume":"70","author":"MJ van den Hoven","year":"2006","journal-title":"Kidney Int"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1093\/ndt\/gft410","article-title":"The role of heparanase and the endothelial glycocalyx in the development of proteinuria","volume":"29","author":"M Garsen","year":"2014","journal-title":"Nephrol Dial Transplant"},{"key":"ref21","first-page":"244","article-title":"Glycosaminoglycan treatment in glomerulonephritis? An interesting option to investigate","volume":"23","author":"G Gambaro","year":"2010","journal-title":"J Nephrol"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1093\/ndt\/gfk076","article-title":"Effects of low molecular weight heparin in obstructed kidneys: decrease of collagen, fibronectin and TGF-beta, and increase of chondroitin\/dermatan sulfate proteoglycans and macrophage infiltration","volume":"21","author":"IM Pecly","year":"2006","journal-title":"Nephrol Dial Transplant"},{"key":"ref23","first-page":"210","article-title":"Heparin reduces glomerular infiltration and TGF-beta protein expression by macrophages in puromycin glomerulosclerosis","volume":"16","author":"M Ceol","year":"2003","journal-title":"J Nephrol"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1038\/ki.1994.335","article-title":"Treatment with a glycosaminoglycan formulation ameliorates experimental diabetic nephropathy","volume":"46","author":"G Gambaro","year":"1994","journal-title":"Kidney Int"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"2324","DOI":"10.1681\/ASN.V11122324","article-title":"Glycosaminoglycan therapy prevents TGF-beta1 overexpression and pathologic changes in renal tissue of long-term diabetic rats","volume":"11","author":"M Ceol","year":"2000","journal-title":"J Am Soc Nephrol"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"e54501","DOI":"10.1371\/journal.pone.0054501","article-title":"Sulodexide decreases albuminuria and regulates matrix protein accumulation in C57BL\/6 mice with streptozotocin-induced type I diabetic nephropathy","volume":"8","author":"S Yung","year":"2013","journal-title":"PLoS One"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1186\/1479-5876-10-213","article-title":"A new mechanism of action of sulodexide in diabetic nephropathy: inhibits heparanase-1 and prevents FGF-2-induced renal epithelial-mesenchymal transition","volume":"10","author":"V Masola","year":"2012","journal-title":"J Transl Med"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1046\/j.1523-1755.2001.060003935.x","article-title":"Low-molecular-weight heparin prevents high glucose- and phorbol ester-induced TGF-beta 1 gene activation","volume":"60","author":"C Weigert","year":"2001","journal-title":"Kidney Int"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1093\/glycob\/cwr038","article-title":"Inhibitory effects of glycosaminoglycans on basal and stimulated transforming growth factor-\u03b21 expression in mesangial cells: biochemical and structural considerations","volume":"21","author":"M Bacilieri","year":"2011","journal-title":"Glycobiology"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1093\/ndt\/12.11.2295","article-title":"A randomized, controlled study of sulodexide therapy for the treatment of diabetic nephropathy","volume":"12","author":"I Dedov","year":"1997","journal-title":"Nephrol Dial Transplant"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1097\/01.ASN.0000014254.87188.E5","article-title":"Oral sulodexide reduces albuminuria in microalbuminuric and macroalbuminuric type 1 and type 2 diabetic patients: the Di.N.A.S. randomized trial","volume":"13","author":"G Gambaro","year":"2002","journal-title":"J Am Soc Nephrol"},{"key":"ref32","first-page":"415","article-title":"Efficacy of low-dose oral sulodexide in the management of diabetic nephropathy","volume":"23","author":"S Blouza","year":"2010","journal-title":"J Nephrol"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1053\/j.ajkd.2011.06.020","article-title":"Sulodexide for kidney protection in type 2 diabetes patients with microalbuminuria: a randomized controlled trial","volume":"58","author":"EJ Lewis","year":"2011","journal-title":"Am J Kidney Dis"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1681\/ASN.2011040378","article-title":"Sulodexide fails to demonstrate renoprotection in overt type 2 diabetic nephropathy","volume":"23","author":"DK Packham","year":"2012","journal-title":"J Am Soc Nephrol"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1053\/j.ajkd.2012.01.029","article-title":"Discounting the efficacy of sulodexide in diabetic nephropathy is premature","volume":"60","author":"G Gambaro","year":"2012","journal-title":"Am J Kidney Dis"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1046\/j.1365-2141.1998.00769.x","article-title":"Antithrombotic activity of a fucosylated chondroitin sulfate from echinoderm: sulfated fucose branches on the polysaccharide account for its antithrombotic action","volume":"101","author":"PA Mour\u00e3o","year":"1998","journal-title":"Br J Haematol"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"14984","DOI":"10.1074\/jbc.M610560200","article-title":"Selectin blocking activity of a fucosylated chondroitin sulfate glycosaminoglycan from sea cucumber. Effect on tumor metastasis and neutrophil recruitment","volume":"282","author":"L Borsig","year":"2007","journal-title":"J Biol Chem"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"F1299","DOI":"10.1152\/ajprenal.00217.2010","article-title":"Fucosylated chondroitin sulfate attenuates renal fibrosis in animals submitted to unilateral ureteral obstruction: a P-selectin-mediated event?","volume":"299","author":"NM Melo-Filho","year":"2010","journal-title":"Am J Physiol Renal Physiol"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1681\/ASN.2005101032","article-title":"Differential expression of the intermediate filament protein nestin during renal development and its localization in adult podocytes","volume":"17","author":"J Chen","year":"2006","journal-title":"J Am Soc Nephrol"},{"key":"ref40","unstructured":"Mesangial index quantification. Animal Models of Diabetic Complications Consortium (2008) Available: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.amdcc.org\/shared\/showFile.aspx?doctypeid=3&docid=64\" xlink:type=\"simple\">www.amdcc.org\/shared\/showFile.aspx?doctypeid=3&amp;docid=64<\/ext-link>. Accessed 19 September 2011."},{"key":"ref41","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s12307-011-0082-7","article-title":"Significance of heparanase in cancer and inflammation","volume":"5","author":"I Vlodavsky","year":"2012","journal-title":"Cancer Microenviron"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1038\/ki.2012.234","article-title":"Podocyte detachment and reduced glomerular capillary endothelial fenestration promote kidney disease in type 2 diabetic nephropathy","volume":"82","author":"EJ Weil","year":"2012","journal-title":"Kidney Int"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.2337\/diabetes.54.6.1626","article-title":"From the periphery of the glomerular capillary wall toward the center of disease: podocyte injury comes of age in diabetic nephropathy","volume":"54","author":"G Wolf","year":"2005","journal-title":"Diabetes"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"2637","DOI":"10.1093\/ndt\/gfp182","article-title":"Regulation of glomerular heparanase expression by aldosterone, angiotensin II and reactive oxygen species","volume":"24","author":"MJ van den Hoven","year":"2009","journal-title":"Nephrol Dial Transplant"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1046\/j.1523-1755.1999.00639.x","article-title":"Inhibition of glomerular cell apoptosis by heparin","volume":"56","author":"Y Ishikawa","year":"1999","journal-title":"Kidney Int"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1159\/000052614","article-title":"Decreased glomerular expression of agrin in diabetic nephropathy and podocytes, cultured in high glucose medium","volume":"9","author":"BA Yard","year":"2001","journal-title":"Exp Nephrol"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.vph.2013.08.001","article-title":"Alteration of endothelial proteoglycan and heparanase gene expression by high glucose, insulin and heparin","volume":"59","author":"J Han","year":"2013","journal-title":"Vascular Pharmacology"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"8989","DOI":"10.1074\/jbc.M105682200","article-title":"Cloning and characterization of the human heparanase-1 (HPR1) gene promoter: role of GA-binding protein and Sp1 in regulating HPR1 basal promoter activity","volume":"277","author":"P Jiang","year":"2002","journal-title":"J Biol Chem"},{"key":"ref49","first-page":"202","article-title":"Retention of glomerular basement membrane-proteoglycans accompanying loss of anionic site staining in experimental diabetes","volume":"61","author":"DM Templeton","year":"1989","journal-title":"Lab Invest"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"38059","DOI":"10.1074\/jbc.M507997200","article-title":"Synthesis of anticoagulantly active heparan sulfate proteoglycans by glomerular epithelial cells involves multiple 3-O-sulfotransferase isoforms and a limiting precursor pool","volume":"280","author":"EP Girardin","year":"2005","journal-title":"J Biol Chem"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1007\/s001250051489","article-title":"A specific structural alteration in the heparan sulphate of human glomerular basement membrane in diabetes","volume":"43","author":"AS Edge","year":"2000","journal-title":"Diabetologia"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"F722","DOI":"10.1152\/ajprenal.00433.2005","article-title":"Podocyte proteoglycan synthesis is involved in the development of nephrotic syndrome","volume":"291","author":"A Bj\u00f6rson Granqvist","year":"2006","journal-title":"Am J Physiol Renal Physiol"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1093\/glycob\/cwr029","article-title":"Diabetes results in structural alteration of chondroitin sulfate\/dermatan sulfate in the rat kidney: effects on the binding to extracellular matrix components","volume":"21","author":"D Joladarashi","year":"2011","journal-title":"Glycobiology"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1369\/0022155413494392","article-title":"Reduced sulfation of chondroitin sulfate but not heparan sulfation kidneys of diabetic db\/db mice","volume":"61","author":"TM Reine","year":"2013","journal-title":"J Histochem Cytochem"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/1475-2840-10-35","article-title":"Changes in cardiac heparan sulfate proteoglycan expression and streptozotocin-induced diastolic dysfunction in rats","volume":"10","author":"CM Strunz","year":"2011","journal-title":"Cardiovasc Diabetol 25"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"F827","DOI":"10.1152\/ajprenal.1998.275.5.F827","article-title":"Increased decorin mRNA in diabetic mouse kidney and in mesangial and tubular cells cultured in high glucose","volume":"275","author":"A Mogyorosi","year":"1998","journal-title":"Am J Physiol Renal Physiol"},{"key":"ref57","doi-asserted-by":"crossref","unstructured":"Rops A, Loeven MA, van Gemst JJ, Eversen I, Van Wijk XM, <etal>et al<\/etal>.. (2014) Modulation of heparan sulfate in the glomerular endothelial glycocalyx decreases leukocyte influx during experimental glomerulonephritis. Kidney Int Apr 23. doi:10.1038\/ki.2014.115.","DOI":"10.1038\/ki.2014.115"},{"key":"ref58","doi-asserted-by":"crossref","first-page":"2200","DOI":"10.1007\/s00125-006-0319-z","article-title":"Functional and molecular alterations of the glomerular barrier in long-term diabetes in mice","volume":"49","author":"M Jeansson","year":"2006","journal-title":"Diabetologia"},{"key":"ref59","doi-asserted-by":"crossref","first-page":"F40","DOI":"10.1152\/ajprenal.00103.2010","article-title":"High glucose causes dysfunction of the human glomerular endothelial glycocalyx","volume":"300","author":"A Singh","year":"2011","journal-title":"Am J Physiol Renal Physiol"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0106929","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,16]],"date-time":"2022-04-16T07:37:23Z","timestamp":1650094643000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0106929"}},"subtitle":[],"editor":[{"given":"Jean-Claude","family":"Dussaule","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2014,9,5]]},"references-count":59,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2014,9,5]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0106929","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,9,5]]}}}